Relationship between changes of electrocardiogram indexes in chronic heart failure with arrhythmia and serum PIIINP

Yue Wang1, Xiaoke Ma2

  • 1Electrocardiogram Room, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China.

Insights

This study found that elevated serum markers like type III procollagen amino-terminal peptide (PIIINP) and brain natriuretic peptide (BNP) correlate with specific electrocardiogram (ECG) changes in chronic heart failure (CHF) patients with arrhythmia, aiding diagnosis.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Chronic heart failure (CHF) is often accompanied by arrhythmias, impacting patient prognosis.
  • Biomarkers such as serum type III procollagen amino-terminal peptide (PIIINP) and brain natriuretic peptide (BNP) are associated with cardiac remodeling and function.
  • Electrocardiogram (ECG) indexes provide crucial information about cardiac electrical activity and structural changes.

Purpose of the Study:

  • To investigate the relationship between ECG index changes in CHF patients with arrhythmia and serum PIIINP and BNP levels.
  • To evaluate the diagnostic value of ECG indexes, PIIINP, and BNP in identifying slow heart failure.

Main Methods:

  • 101 patients with heart failure were divided into two groups: slow arrhythmia (Group A) and non-slow arrhythmia (Group B).
  • Serum PIIINP and BNP levels were measured using immunoassay and chemiluminescence, respectively.
  • ECG indexes, including heart rate, P-R interval, Q-T interval, and QRS duration, were analyzed.
  • Correlation analysis and Receiver Operating Characteristic (ROC) curve analysis were performed.

Main Results:

  • Serum PIIINP and BNP levels were significantly higher in Group A (slow arrhythmia) compared to Group B.
  • Both PIIINP and BNP levels showed significant differences across NYHA cardiac function classifications (II, III, and IV).
  • ECG indexes such as heart rate and Q-T interval were higher in Group A, while P-R interval and QRS duration were lower.
  • Positive correlations were observed between BNP/PIIINP and heart rate/Q-T interval, and negative correlations with P-R interval and QRS duration. PIIINP also correlated positively with NYHA classification.

Conclusions:

  • ECG indexes are correlated with serum PIIINP and BNP levels in CHF patients with arrhythmia.
  • These biomarkers and ECG findings have diagnostic value for CHF, particularly for slow heart failure.
  • Utilizing ECG indexes to predict BNP and PIIINP levels can aid in the diagnosis and management of CHF.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
482
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
612
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
366
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
252
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
387
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
388